View Article

Abstract

Lemongrass oil, derived from the Cymbopogon species, has been traditionally utilized for its diverse therapeutic properties. This review aims to consolidate and evaluate the scientific evidence regarding its antifungal and antibacterial activities. Lemongrass oil is rich in bioactive compounds, particularly citral, which is primarily responsible for its potent antimicrobial effects. Various in vitro and in vivo studies have demonstrated the efficacy of lemongrass oil against a broad spectrum of bacterial and fungal pathogens. The mechanisms of action include disruption of microbial cell membranes, inhibition of biofilm formation, and interference with microbial enzyme systems. The review also explores the potential applications of lemongrass oil in clinical and agricultural settings, emphasizing its role as a natural alternative to synthetic antimicrobials. Safety profiles and potential resistance issues are also discussed. The findings support the integration of lemongrass oil in antimicrobial strategies, highlighting its promise in combating infections and enhancing food safety.

Keywords

Lemongrass oil, Cymbopogon, antifungal, antibacterial, citral, geraniol, limonene, antimicrobial activity, biofilm inhibition, antibiotic resistance, essential oils

Introduction

Lemongrass oil has a strong lemon-like odour due to high citral content (75-90%). The minimum commercial requirement is 70% citral content. The major quality checking measures are its citral content and its solubility in alcohol. This is an essential ingredient in toiletry products such as toilet soaps, bath salts, etc.It is also employed in artificial lemon flavouring and in the manufacture of ionenes. Ionenes are very important for the production of artificial flavour, perfumes, and soaps and as raw material for vitamin A manufacturing. Here in this article, we intend to explore how to start a small-scale lemongrass oil manufacturing business. The oil is of a reddish-yellow to reddish-brown colour, with a strong, lemon odour. It is also used in pharmaceutical preparations, such as pain balm, disinfectants, and mosquito repellent cream. Lemon grass, popularly known as citronella grass is a member of the Poaceae family and belongs to the genus Cymbopogon. The genus Cymbopogon constitutes of approximately 140 species that show widespread growth across the semi-temperate and tropical regions of Asian, American and African continents. Australia and Europe are home to only a few species of lemon grass. Also known as ‘Squinant’ in English, lemon grass is known by various other colloquial names throughout the world. The members of the Cymbopogon genus produce volatile oils and thus are also known as aromatic grasses.1,2A strong lemon fragrance, a predominant feature of this grass, is due to the high citral content of its oil. The redolence of the oil enables its use in soaps, detergents, etc. As a good source of citral, it finds an application in the perfumery as well as food industries. It is also the starting material for the manufacture of ionone’s, which produce Vitamin A.3Lemon grass contains several bioactive compounds that impart medicinal value to it. Considerable evidence is available for its ethnopharmacological applications.4 According to the WHO, herbal medicine is considered an important part of the healthcare industry by more than two-thirds of the population in developing countries. A part from an overall description of lemon grass, this review article also highlights its medicinal properties that make it a potent herb for Pharmacognstic applications. Cymbopogon spp. are fast-growing C4 perennial sedges from the grass family Poaceae and are primarily cultivated for their essential oils. The genus lemongrass comprises about 180 species, such as Cymbopogon citratus, Cymbopogon flexuosus, Cymbopogon winterianus, Cymbopogon martinii, Cymbopogon nardus, and Cymbopogon refractus. These aromatic grasses are of great commercial interest due to their wide applications in different areas such as the food, pharmaceutical, and cosmetic industries. The plant propagates through seed and slips and has thin and lanceolate leaves that appear to emerge directly from the soil without any stem Although lemongrass cultivation is cosmopolitan, India has a monopoly over its production and export. Bioactive Compounds Present in Lemon Grass and its OilA vast array of ethnopharmacological applications of lemon grass exist today. Its health restorative capacity may be ascribed to the diverse secondary metabolites it produces. Analysis of the grass showed the presence offats, proteins, carbohydrates, fiber, minerals and several other bioactive compounds (Table 1-3). These can be grouped under different classes like alkaloids, terpenoids, flavanoids, phenols, saponins and tannins. Reports have also confirmed the presence of anthraquinones, steroids, phlobotannins, and cardiac glycosides in lemon grass.



       
            Picture9.jpg
       

   Cymbopogon citratus


Scientific classification-:

Kingdom: plantae

Clade: Tracheophytes

Clade: Monocots

Clade: Commelinids

Order: Poalrs

Family: Poaceae

Subfamily; panicoideae

Subertribe: Andropogonodae

Tribe: Andropogonodae

Subtribe: Andropogoninae

Genus: Cymbopogon

Types Species:

Cymbopogon Schoenanthus

Nanosponges:                                                                                                                                     

While designing a drug delivery system, researchers mainly focus on delivering the accurate amount of drug at the target site. In this way, many approaches are utilized by using modern nanotechnology, which proved best in its manner.1 Nanotechnology is a branch of science that employs nanomaterials at the nanoscale for creating nanoengineered products with advanced features and improved characteristics in the size range of 1 to 100 nm. One billionth of a meter is a nanometer. Nanomaterials are physical compounds with at least one fraction in the range of 1 to 100 nm. 2. These NPs are observed in a number of diverse shapes, including polymeric nanoparticles, hard-phospholipid nanoparticles, nanoemulsions, dendrimers, nanosponges, liposomes, carbon nanotubes, micellar systems, etc.3 In this regard, the use of nanotechnology in the medical field is transitioning from passive structures’ to ‘active structures’ through more precise pharmacological drug therapies or “smart drugs” that are made by coupling certain ligands to nanocarriers or aptamers. A wide variety of drug substances like antifungal, antiviral, anti-cancer, volatile oils, gases, proteins and peptides can be ensnared in colloidal nanoparticulate structures known as nanosponges.



       
            Picture10.jpg
       

    


NS are 3D spongy structures, around the size of a virus containing nanometric cavities or voids. Simply they are encapsulating drug delivery systems.4,5 These sponges move all around the body until they identify the exact target, attach to the surface, and release the drug gradually. They are five times more efficient than conventional techniques at delivering drugs for breast cancer and are non-irritating, non-mutagenic, non-allergic, and non-toxic.6 NS are solid by nature, capable of ensnaring both hydrophilic and lipophilic substances. Due to this property, they are suitable for enhancing the solubility, permeability as well as bioavailability of compromised drugs like camptothecin, paclitaxel, dexamethasone, etc. It also helps less or poor water-soluble molecules become more soluble by encapsulating them in polar cavities. They are porous, insoluble in water and other organic solvents, innocuous and stable up to 300?.

The development of nanosponges involves the use of many polymers and cross-linkers which result in the delivery of entrapped drugs in a controlled predictable way at the target site.7 In this way, NS is the leading frontier in drug delivery which reduces the dose and dose-related toxicities. It can be administered through oral, parenteral, and topical routes. Oral administration of NS can be done in the form of capsules, tablets, or solid dispersions by using suitable excipients and diluents that deliver the drug efficiently at the target site.8 For the parenteral route different aqueous solutions like sterile water, and saline is used for NS dispersion while in topical delivery hydrogel is best suited. This ultimately results in improved safety, effectiveness, patient compliance, an extended drug shelf life, and ultimately lower healthcare expenditures. Nanotechnology has the potential to be the most significant engineering breakthrough since the industrial revolution. Nanotechnology has so far produced nanoparticles, nanocapsules, nanospheres, nano suspensions, nanocrystals, and nano-erythosomes, among other formulations. Nanotechnology is described as the synthesis and manipulation of materials at the nanoscale level in order to produce products with unique features. Nanomaterials have received a lot of interest in recent years. Richard P. Feynman, a physicist at Cal Tech, predicted nanomaterials in 1959. "There is lots of room at the bottom," he remarked, suggesting that scaling down to the nanoscale and beginning from the bottom was the key are materials with a minimum of one dimension within the vary of 1-100 nanometers.1 There are many different types of nanoparticles, including polymeric nanoparticles, solid-lipid nanoparticles, nanoemulsions, nanosponges, carbon nanotubes, micellar systems, and dendrimers, among others. The compound can simply be transported for parenteral distribution in sterile water, saline, or other aqueous solutions. They can successfully be incorporated into topical hydrogel for topical administration. Nanosponges are a novel class of materials made up of small particles having a few nanometer-wide holes that may encapsulate a wide range of compounds. These particles are capable of transporting both lipophilic and hydrophilic molecules, as well as enhancing the solubility of molecules that are weakly water soluble. These microscopic sponges can move through the body until they reach the intended target region, where they adhere to the surface and start to release the medicine in a steady and controlled manner. For a given dosage, the drug will be more effective since it can be released at the precise target place rather than circulating throughout the body. These nanosponges also have an important property called aqueous solubility, which makes it possible to use these systems successfully for medications with limited solubility.

Advantages of Nanosponges:

  • Nanosponges allows components to be entrapped and thus reduces adverse effects.
  • Remains stable at pH levels ranging from 1 to 11.
  • They can withstand temperatures of up to 1300°C.
  • They act like self-sterilizer, because of their tiny pore size (0.25m) which does not allow bacteria to penetrate.
  • They are of low-cost and free-flowing.
  • They improve the solubility of drugs that aren't easily soluble.
  • They increase the bioavailability of drug.
  • They have improved formulation flexibility, improved stability, and increased elegance.
  • Increase aqueous solubility of the poorly water-soluble drug.
  • Nanosponges can release the drug molecules in a predictable fashion.                           Because of their tiny pore size (0.25 ?m), bacteria cannot penetrate the nanosponges and they act like a self-sterilizer.
  • Nanosponges drug delivery system are non-irritating, non- mutagenic and non-toxic.
  • Nanosponges help to remove the toxic and venom substance from the body.
  • Nanosponges drug delivery system minimize side effect.
  • Increase formulation stability and enhance the flexibility of the formulation.
  • Reduce dosing frequency.
  • Better patient compliance.
  • Nanosponges complexes are stable over wide range of pH (i.e. 1- 11) and a temperature of 130 °C [4-6].  

Characteristics of Nanosponges-

There are several characteristics of nanosponges which make it different from other nanoparticles. Such characteristics are being discussed below:

  • Nanosponges are insoluble in organic solvents & water porous, nontoxic, and thermostable up to 3000C, unlike other nanoparticles.
  • Their size distribution is limited, with a mean diameter of less than 1 m.
  • Carbonate nanosponges have a zeta potential of about 25 mV, which results with stable water suspensions that do not aggregate over time due to a higher zeta
  • potential.
  • Nanosponges protect the medication from physiological breakdown and are non-irritating, non- mutagenic, non-allergic, and non-toxic.
  • By generating inclusion and non-inclusion complexes nanosponges can encapsulate a variety of pharmacological compounds.
  • Nanosponges are porous particles that are primarily utilized to encapsulate medications that are poorly soluble.

 Composition Of Nanosponges -

1. Polymer and copolymers -

The choice of polymer can have an impact on the development and performance of nanosponges. The cavity  size must be appropriate for incorporating the specific medication molecule. The polymer chosen is determined by the needed release and the medicine to be encapsulated. The chosen polymer should have the ability to bind to specified ligands. Eg. Cyclodextrins and their derivatives such as Methyl- cyclodextrin (-CD), alkyloxy carbonyl cyclodextrins, 2- hydroxy propyl-CDs, and copolymers such as poly (Valero lactoneallylvalero lactone) and poly (Valero lactone-allyl Valero lactone oxepanedione), Hyper cross-linked polystyrenes, ethyl cellulose and PVA are among the polymers used to make nanosponges.

2. Cross linking agents -

The cross-linking agent can be selected based on the structure of the polymer and the medicine that will be synthesized. Depending on the type of cross linkers used, water soluble or insoluble nanosponge structures are created. Examples: Diphenyl Carbonate, Diarylcarbonates, Di- Isocyanates, Pyromellitic anhydride, Carbonyl-di- Imidazoles, Epichloridrine, Glutaraldehyde, Carboxylic acid dianhydrides, 2,2-bis(acrylamido) Acetic acid and Dichloromethane.                                                   

Factors Formulation Of Nanosponges -Affecting

  1. Type of Drug
  2. Type of Polymer used
  3. Temperature
  4. Method of preparation nanosponge
  5. Degree of substitution

1.Type of Drug

The therapeutic molecules that will be used in incision and non-incision nanosponge complexes should have the following characteristics:

  1. The drug molecule's structure should not include more than five condensed rings.
  2. The drug's melting point should be less than 250°C.
  3. In water, drug solubility should be less than 10 mg/ml.
  4. The molecular weight of drug should be between 100 and 400 gm/mole.

2. Type of Polymers Used

The type of polymer employed in nanosponge formulation can have an impact on the nanosponge formation and performance. The polymer utilised in the formulation determines the size of the nanosponge cavity and drug complexation.

3. Temperature

The drug/nanosponge complexation can be affected b temperature changes. Reduces the perceived stability's magnitude by a factor of two. The constant increase in temperature of the Drug/Nanosponge complex could be related to the likely lowering of drug/Nanosponge contact forces as temperature rises.

4. Method of Preparation Nanosponges

The loading of a drug into a nanosponge has the potential to change the nanosponge/drug complexation. In any instance, the success of a method is determined by the nature of the drug and polymer. Freeze drying has proven to be the most effective way for drug complexation in many cases.

5. Degree of Substitution

The type, amount, and placement of the substituent on the parent molecule can all affect the ability of nanosponge to complex.

Method Prepration  Of  Nanosponges -

<span style="font-family:&q

Reference

  1. Alka Sing, et al, (Oct 2023). International Journal Of Pharmaceutical Quality Assurance & Pharmaceutical Analysis. Nanosponges-A Versatile Apporoach of Drug Delivery System.14,1246-1255.
  2. Verma S, et al. (Sep 2023). Biomedical and Pharmacology Journal . Nanoparticles-A Booming Drug Delivery System in Chemotherapy.l;16(3):1785-90.
  3. Tiwari K, et al. (Mar2022). Journal of Materials Science: Materials in Medicine .The ascension of nanosponges as a drug delivery carrier: Preparation, characterization, and applications;33(3):28.
  4. Jain A,et al .(Jun 2020). Journal of drug delivery science and technology. Engineered was versatile biodegradable carriers: An insight. 101643
  5. Tannous M ,et al. (Mar 2020). Nanosponges for combination drug therapy: State-of-the-art and future directions. Nanomedicine. 15(07):643-6.
  6. Pawar S, et al, (Jun 2019). International Journal of Pharmaceutics.Diversity of ?-cyclodextrin-based nanosponges for transformation of actives.30:333-50.
  7. Anwar W, et al. (2019). Universal Journal of Pharmaceutical Research. Screening study for formulation variables in preparation and characterization of candesartan cilexetil loaded nanostructured lipid carriers; 4(6): 8-19.
  8. Patra JK, et al .(Dec 2018). . Journal of Nanobiotechnology. Nano based drug delivery systems: recent developments and future prospects.16(1):1-33.
  9. Mishra R,et al .(Nov2018). Nature, nanoscience, and textile structures. Nanotechnology in Textiles: Theory and Application. 
  10. Alka S. (2017). World Jornal of Pharmacy and Pharmaceutical Sciences. Development and evaluation of cyclodextrin based nanosponges for bioavailability enhancement of poorly bioavailable drug; 6:805-36.
  11. Wadekar Pradnya Pradeep, et al. (2017).  Universal Journal of Pharmaceutical Research . A review on gold nanoparticles synthesis and characterization; 2(4): 65-69.
  12. Desai MA, et al, (2015), Extraction of essential oil from leaves of lemongrass using microwave radiation: optimization, comparative, kinetic, and biological studies, ACS Sustainable Chemistry & Engineering, 3, 421-431.
  13. Avoseh O, et al, (2015), Cymbopogon species; ethnopharmacology, phytochemistry and the pharmacological importance, Molecules, 20, 7438-7453.
  14. Chime, S.A.et al, (2014). Nanoemulsions-Advances in Formulation, Characterization and Applications in Drug Delivery, Ali DS, Application of Nanotechnology in Drug Delivery, Crotia: In Tech; 77-111.
  15. 15.Ekpenyong CE, et al, (2014). Journal of Pharmacognosy and Phytochemistry. Phytochemical constituents, therapeutic applications and toxicological profile of Cymbopogoncitratus Stapf (DC) leaf extract, 3,133-141.
  16. Halabi MF, et al, (2014). BioMed Research International. Anti-proliferative effect and phytochemical analysis of Cymbopogoncitratus extract, 1-8.
  17. Boukhate , et al ,(2014)." Libyan Journal of Medicine. "Lemongrass (Cymbopogon citratus) essential oil as a potent anti-inflammatory and antifungal drugs, 9(1), 25431.
  18. AH NA, Zaibunnisa AH, etal, (2013). International Food Research Journal.  An experimental design approach for the extraction of lemongrass (Cymbopogoncitratus) oleoresin using pressurized liquid extraction (PLE), 451-455.
  19. Garg D, et al, (2012). Research Journal of Pharmaceutical, Biological and Chemical Sciences. Comparative analysis of phytochemical profile and antioxidant activity of some Indian culinary herbs, 3, 845-854.
  20. Joshua AA, et al, (2012), Journal of Medical Sciences, Comparative studies on the chemical composition and antimicrobial activities of the ethanolic extracts of lemon grass leaves and stems, Asian 4, 145-148.
  21. Mirghani MES, et al, (2012). International Food Research Journal. Bioactivity analysis of lemongrass (Cymbopogancitratus) essential oil, 19, 569-575.               
  22. Garg D, et al, (2012). Research Journal of Pharmaceutical, Biological and Chemical Sciences. Comparative analysis of phytochemical profile and antioxidant activity of some Indian culinary herbs, 3, 845-854.
  23. Lovelyn, C.et al. (2011), Journal of Biomaterials and Nanobiotechnology.  Current State of Nanoemulsions in Drug Delivery ; 2: 626-639.
  24. 24.Tyagi, A. K., et al, (2010)."Antimicrobial potential and chemical composition of lemongrass (Cymbopogon citratus) oil against food-borne pathogens and spoilage microorganisms." International Journal of Food Microbiology, 144(1), 75-80.
  25. Fagbohun ED, et al, (2010), International Journal of Pharmaceutical Sciences Review and Research. Chemical composition and antibacterial activities of some selected traditional medicinal plants used in the treatment of gastrointestinal infections in Nigeria, 5, 192-197.
  26. Asaolu MF, et al, (2009). Pakistan Journal of Nutrition.Chemical compositions, phytochemical constituents and in vitro biological activity of various extracts of Cymbopogon citratus, 8, 1920-1922.
  27. Oloyede OI, (2009). Journal of Natural Products, Chemical profile and antimicrobial activity of Cymbopogoncitratus leaves,2, 98-103.
  28. Asaolu MF, et al, (2009). Pakistan Journal of Nutrition.Chemical compositions, phytochemical constituents and in vitro biological activity of various extracts of Cymbopogon citratus, 8, 1920-1922.
  29. Oloyede OI, (2009). Journal of Natural Products, Chemical profile and antimicrobial activity of Cymbopogoncitratus leaves,2, 98-103.
  30. Marongiu B, et al, (2006), Natural Product Research, Comparative analysis of the oil and supercritical CO2 extract of Cymbopogon citratus Stapf, 20, 455-459.
  31. Jafari, S.M. et al. (2006), International Journal of Food Properties. Nanoemulsion production by sonication and microfluidization: A comparison; 9: 475–485.
  32. Koul VK, et a, (2004), Indian Journal of Chemical Technology, Steam distillation of lemon grass (Cymbopogon spp.), 1, 135-139.
  33. Akhila, A , et al, (1984) . Indian Journal of Pharmaceutical Sciences . "Antimicrobial activity of essential oil of Indian lemongrass.", 46(5), 192-194.
  34. Onawunmi, G. O.et al.  (1984). Journal of Ethnopharmacology. "Antibacterial constituents in the essential oil of Cymbopogon citratus.", 12(3), 279-286
  35. Mishra, A. K.et al, (1994). Applied and Environmental Microbiology. "Evaluation of some essential oils for their toxicity against fungi causing deterioration of stored food commodities.", 60(4), 1101-1105.
  36. Hammer, K. A.et al. (1999). Journal of Applied Microbiology. "Antimicrobial activity of essential oils and other plant extracts .86(6), 985-990.

Photo
Shaikh S. S.
Corresponding author

Associate Professor of Siddhi’s institute of pharmacy, Nandgaon, MS, India -421401.

Photo
Gajanan Bagul
Co-author

Research scholar of Siddhi’s institute of pharmacy, Nandgaon, MS, India -421401.

Photo
Vishal Gavhad
Co-author

Research scholar of Siddhi’s institute of pharmacy, Nandgaon, MS, India -421401.

Photo
Mayur Gaikwad
Co-author

Research scholar of Siddhi’s institute of pharmacy, Nandgaon, MS, India -421401.

Photo
Omkar Dorge
Co-author

Research scholar of Siddhi’s institute of pharmacy, Nandgaon, MS, India -421401.

Gajanan Bagul, Vishal Gavhad, Mayur Gaikwad, Omkar Dorge, Shaikh S. S. , A Review On Lemongrass Oil Act As A Antifungal And Anti-Bacterial Agent, Int. J. of Pharm. Sci., 2024, Vol 2, Issue 7, 868-890. https://doi.org/10.5281/zenodo.12737827

More related articles
In Vitro Anti inflammatory Activity Of Glochidion ...
Eknath V. Unde , Sneha B. Fand , Amol S. Darade , Ganesh R. Gosav...
Navigating Of DEVIC’S Diseasse: Symptoms, Diagno...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P....
Safety And Efficacy Of Diuretics With Reduced Ejec...
G. Anjani Tejaswi, P. Shaheera, A. Navya Sree, M. Bala Tripura Su...
Clinical Data Management: A Comprehensive Overview Of Methods And Workflow In Cl...
Akash Bhagwan Aher, Atharv Chagan Gadhe, Prashant Vilas Bhakare, Prof.Shweta Kahar, Prof.Kranti Pakh...
Studies on the Evaluation of Flavonoids (Morin, Naringin, Quercetin & Rutin) in ...
Dr. Raja Kumar Parabathina, Vishal Lolge, Sunil Kothargasti, Sanika Girgaonkar, Nidhi Dubey, ...
An Overview Of The Background, Causes, Diagnosis, Pathophysiology, Screening Met...
Deepak Venkataraman N, Charumathi P, Bharadwaj J, Lakshminarasimman S, Purushothaman S, Sudharsan S,...
Related Articles
Non-Effervescent Gastro-Retentive Tablets For Controlled Release Of Pregabalin...
Chandani Rajak, Meenakshi Kandwal, Shivanand Patil, ...
In Vitro Anti inflammatory Activity Of Glochidion Zeylanicum A. Juss. Leaves Ext...
Eknath V. Unde , Sneha B. Fand , Amol S. Darade , Ganesh R. Gosavi, Archana S. Murgunde, ...
More related articles
In Vitro Anti inflammatory Activity Of Glochidion Zeylanicum A. Juss. Leaves Ext...
Eknath V. Unde , Sneha B. Fand , Amol S. Darade , Ganesh R. Gosavi, Archana S. Murgunde, ...
Navigating Of DEVIC’S Diseasse: Symptoms, Diagnosis, And Care...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P., ...
Safety And Efficacy Of Diuretics With Reduced Ejection Fraction In Heart Failure...
G. Anjani Tejaswi, P. Shaheera, A. Navya Sree, M. Bala Tripura Sundari, P. Seetaramayya, Velaga Mahe...
In Vitro Anti inflammatory Activity Of Glochidion Zeylanicum A. Juss. Leaves Ext...
Eknath V. Unde , Sneha B. Fand , Amol S. Darade , Ganesh R. Gosavi, Archana S. Murgunde, ...
Navigating Of DEVIC’S Diseasse: Symptoms, Diagnosis, And Care...
Daphne Sherine, Thrisha R., Srimathi P., Oviya M. Kaviyarasan P., ...
Safety And Efficacy Of Diuretics With Reduced Ejection Fraction In Heart Failure...
G. Anjani Tejaswi, P. Shaheera, A. Navya Sree, M. Bala Tripura Sundari, P. Seetaramayya, Velaga Mahe...